Alterations in adaptive immunity persist during long-duration spaceflight

npj Microgravity

Volumn 1, Issue , 2015, Pages

  Crucian, Brian ^a   Stowe, Raymond P ^b   Mehta, Satish ^c   Quiriarte, Heather ^d   Pierson, Duane ^a   Sams, Clarence ^e  

^a NASA JOHNSON SPACE CENTER   (United States)

^b Microgen Laboratories   (United States)

^c Enterprise Advisory Services Inc   (United States)

^d FINA Oil and Chemical   (United States)

^e Space and Clinical Operations Division ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CYTOLOGY; IMMUNE SYSTEM; INDIUM COMPOUNDS; INTERPLANETARY FLIGHT; MANNED SPACE FLIGHT; ORBITS; SPACE STATIONS; VIRUSES;

ACTIVATION THRESHOLDS; ADAPTIVE IMMUNITY; CYTOKINE PRODUCTION; DEEP SPACE MISSIONS; DIFFERENTIAL RESPONSE; INTERNATIONAL SPACE STATIONS; LIPOPOLYSACCHARIDES; WHITE BLOOD CELLS;

T-CELLS;

EID: 85038012068     PISSN: None     EISSN: 23738065     Source Type: Journal    
DOI: 10.1038/npjmgrav.2015.13     Document Type: Article

References (38)

1. Chapes SK, Morrison DR, Guikema JA, Lewis ML, Spooner BS. Production and action of cytokines in space. Adv Space Res 1994; 14: 5–9.
2. Crucian BE, Stowe RP, Pierson DL, Sams CF. Immune system dysregulation following short-vs long-duration spaceflight. Aviat Space Environ Med 2008; 79: 835–843.
3. Sonnenfeld G, Miller ES. The role of cytokines in immune changes induced by spaceflight. J Leukoc Biol 1993; 54: 253–258.
4. Sonnenfeld G. Effect of space flight on cytokine production. Acta Astronaut 1994; 33: 143–147.
5. Morukov VB, Rykova MP, Antropova EN, Berendeeva TA, Ponomarev SA, Larina IM. Indicators of innate and adaptive immunity of cosmonauts after long-term space flight to international space station. Fiziol Cheloveka 2010; 36: 19–30.
6. Buravkova LB, Rykova MP, Grigorieva V, Antropova EN. Cell interactions in microgravity: cytotoxic effects of natural killer cells in vitro. J Gravit Physiol 2004; 11: P177–P180.
7. Konstantinova IV, Rykova M, Meshkov D, Peres C, Husson D, Schmitt DA. Natural killer cells after ALTAIR mission. Acta Astronaut 1995; 36: 713–718.
8. Meshkov D, Rykova M. The natural cytotoxicity in cosmonauts on board space stations. Acta Astronaut 1995; 36: 719–726.
9. Rykova M, Antropova IM, Larina IM, Morukov BV. Humoral and cellular immunity in comsonauts after the ISS missions. Acta Astronaut 2008; 63: 697–705.
10. Crucian BE, Cubbage ML, Sams CF. Altered cytokine production by specific human peripheral blood cell subsets immediately following space flight. J Interferon Cytokine Res 2000; 20: 547–556.
11. Stowe RP, Sams CF, Mehta SK, Kaur I, Jones ML, Feeback DL et al. Leukocyte subsets and neutrophil function after short-term spaceflight. J Leukoc Biol 1999; 65: 179–186.
12. Kaur I, Simons ER, Castro VA, Ott CM, Pierson DL. Changes in monocyte functions of astronauts. Brain Behav Immun 2005; 19: 547–554.
13. Kaur I, Simons ER, Castro VA, Mark Ott C, Pierson DL. Changes in neutrophil functions in astronauts. Brain Behav Immun 2004; 18: 443–450.
14. Boonyaratanakornkit JB, Cogoli A, Li CF, Schopper T, Pippia P, Galleri G et al. Key gravity-sensitive signaling pathways drive T cell activation. FASEB J 2005; 19: 2020–2022.
15. Cogoli A. The effect of space flight on human cellular immunity. Environ Med 1993; 37: 107–116.
16. Schwarzenberg M, Pippia P, Meloni MA, Cossu G, Cogoli-Greuter M, Cogoli A. Signal transduction in T lymphocytes--a comparison of the data from space, the free fall machine and the random positioning machine. Adv Space Res 1999; 24: 793–800.
17. Stowe RP, Sams CF, Pierson DL. Effects of mission duration on neuroimmune responses in astronauts. Aviat Space Environ Med 2003; 74: 1281–1284.
18. Stowe RP, Sams CF, Pierson DL. Adrenocortical and immune responses following short-and long-duration spaceflight. Aviat Space Environ Med 2011; 82: 627–634.
19. Grove DS, Pishak SA, Mastro AM. The effect of a 10-day space flight on the function, phenotype, and adhesion molecule expression of splenocytes and lymph node lymphocytes. Exp Cell Res 1995; 219: 102–109.
20. Nash PV, Konstantinova IV, Fuchs BB, Rakhmilevich AL, Lesnyak AT, Mastro AM. Effect of spaceflight on lymphocyte proliferation and interleukin-2 production. J Appl Physiol 1992; 73: 186S–190S.
21. Pellis NR, Goodwin TJ, Risin D, McIntyre BW, Pizzini RP, Cooper D et al. Changes in gravity inhibit lymphocyte locomotion through type I collagen. In Vitro Cell Dev Biol Anim 1997; 33: 398–405.
22. Taylor GR, Janney RP. In vivo testing confirms a blunting of the human cell-mediated immune mechanism during space flight. J Leukoc Biol 1992; 51: 129–132.
23. Crucian B, Stowe R, Mehta S, Uchakin P, Quiriarte H, Pierson D et al. Immune system dysregulation occurs during short duration spaceflight on board the space shuttle. J Clin Immunol 2012; 33: 456–465.
24. Payne DA, Mehta SK, Tyring SK, Stowe RP, Pierson DL. Incidence of Epstein-Barr virus in astronaut saliva during spaceflight. Aviat Space Environ Med 1999; 70: 1211–1213.
25. Mehta SK, Stowe RP, Feiveson AH, Tyring SK, Pierson DL. Reactivation and shedding of cytomegalovirus in astronauts during spaceflight. J Infect Dis 2000; 182: 1761–1764.
26. Mehta SK, Cohrs RJ, Forghani B, Zerbe G, Gilden DH, Pierson DL. Stress-induced subclinical reactivation of varicella zoster virus in astronauts. J Med Virol 2004; 72: 174–179.
27. Mehta SK, Laudenslager ML, Stowe RP, Crucian BE, Sams CF, Pierson DL. Multiple latent viruses reactivate in astronauts during Space Shuttle missions. Brain Behav Immun 2014; 41: 210–217.
28. Pierson DL, Stowe RP, Phillips TM, Lugg DJ, Mehta SK. Epstein-Barr virus shedding by astronauts during space flight. Brain Behav Immun 2005; 19: 235–242.
29. Mehta SK, Crucian BE, Stowe RP, Simpson RJ, Ott CM, Sams CF et al. Reactivation of latent viruses is associated with increased plasma cytokines in astronauts. Cytokine 2013; 61: 205–209.
30. Gmunder FK, Konstantinova I, Cogoli A, Lesnyak A, Bogomolov W, Grachov AW. Cellular immunity in cosmonauts during long duration spaceflight on board the orbital MIR station. Aviat Space Environ Med 1994; 65: 419–423.
31. Shibuya TY, Wei WZ, Zormeier M, Ensley J, Sakr W, Mathog RH et al. Anti-CD3/ anti-CD28 bead stimulation overcomes CD3 unresponsiveness in patients with head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1998; 126: 473–479.
32. Hashemi BB, Penkala JE, Vens C, Huls H, Cubbage M, Sams CF. T cell activation responses are differentially regulated during clinorotation and in spaceflight. Faseb J 1999; 13: 2071–2082.
33. Crucian BE, Stowe RP, Mehta SK, Yetman DL, Leal MJ, Quiriarte HD et al. Immune status, latent viral reactivation, and stress during long-duration head-down bed rest. Aviat Space Environ Med 2009; 80: A37–A44.
34. Stowe RP, Yetman DL, Storm WF, Sams CF, Pierson DL. Neuroendocrine and immune responses to 16-day bed rest with realistic launch and landing G profiles. Aviat Space Environ Med 2008; 79: 117–122.
35. Rykova MP, Sonnenfeld G, Lesnyak AT, Taylor GR, Meshkov DO, Mandel AD et al. Effect of spaceflight on natural killer cell activity. J Appl Physiol 1985; 73: 196S–200S.
36. Manz BN, Jackson BL, Petit RS, Dustin ML, Groves J. T-cell triggering thresholds are modulated by the number of antigen within individual T-cell receptor clusters. Proc Natl Acad Sci USA 2011; 108: 9089–9094.
37. Pierson D, Mehta S, Stowe R. Reactivation of latent herpes viruses in Astronauts. In: Ader R, Psychoneuroimmunology. Elsevier, Inc.: Atlanta, GA, 2007, pp 851–868.
38. Crucian BE, Zwart SR, Mehta S, Uchakin P, Quiriarte HD, Pierson D et al. Plasma cytokine concentrations indicate that in vivo hormonal regulation of immunity is altered during long-duration spaceflight. J Interferon Cytokine Res 2014; 34: 778–786.